Charles Schwab Investment Management Inc Terns Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 206,450 shares of TERN stock, worth $924,896. This represents 0.0% of its overall portfolio holdings.
Number of Shares
206,450
Previous 154,714
33.44%
Holding current value
$924,896
Previous $1.29 Million
10.78%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TERN
# of Institutions
175Shares Held
80.4MCall Options Held
580KPut Options Held
454K-
Orbimed Advisors LLC San Diego, CA7.56MShares$33.9 Million1.49% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$30.9 Million8.42% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.22MShares$27.9 Million4.41% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$25 Million1.71% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$18.5 Million0.0% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $169M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...